ES2028430T3 - Preparaciones efervescentes de ibuprofen. - Google Patents

Preparaciones efervescentes de ibuprofen.

Info

Publication number
ES2028430T3
ES2028430T3 ES198989120046T ES89120046T ES2028430T3 ES 2028430 T3 ES2028430 T3 ES 2028430T3 ES 198989120046 T ES198989120046 T ES 198989120046T ES 89120046 T ES89120046 T ES 89120046T ES 2028430 T3 ES2028430 T3 ES 2028430T3
Authority
ES
Spain
Prior art keywords
ibuprofen
effervescent preparations
ibuprophen
effervescent
otabletas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989120046T
Other languages
English (en)
Spanish (es)
Inventor
Christian Dr. Fritsch
Werner Grawingholt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6367061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2028430(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2028430T3 publication Critical patent/ES2028430T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES198989120046T 1988-11-12 1989-10-28 Preparaciones efervescentes de ibuprofen. Expired - Lifetime ES2028430T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3838431A DE3838431A1 (de) 1988-11-12 1988-11-12 Ibuprofen-brausezubereitungen

Publications (1)

Publication Number Publication Date
ES2028430T3 true ES2028430T3 (es) 1992-07-01

Family

ID=6367061

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989120046T Expired - Lifetime ES2028430T3 (es) 1988-11-12 1989-10-28 Preparaciones efervescentes de ibuprofen.

Country Status (12)

Country Link
US (1) US5445827A (https=)
EP (1) EP0369228B1 (https=)
JP (1) JP2735903B2 (https=)
AT (1) ATE70438T1 (https=)
AU (1) AU616066B2 (https=)
CA (1) CA2002732A1 (https=)
DE (2) DE3838431A1 (https=)
ES (1) ES2028430T3 (https=)
FI (1) FI895342A7 (https=)
GR (1) GR3003685T3 (https=)
HU (2) HU202103B (https=)
PT (1) PT92271B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
KR100198044B1 (ko) 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
EP0642784B1 (de) * 1993-09-07 1999-05-19 Gerhard Dr. Gergely Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
GB9426218D0 (en) * 1994-12-23 1995-02-22 Procter & Gamble Processes of preparing pharmaceutical compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ITMI20020557A1 (it) * 2002-03-15 2003-09-15 Acraf Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
DE602004031462D1 (de) * 2003-12-31 2011-03-31 Cima Labs Inc Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
CA2549642C (en) * 2003-12-31 2012-10-30 Cima Labs Inc. Effervescent oral opiate dosage forms and methods of administering opiates
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP2559430B1 (en) 2005-03-22 2015-06-24 Losan Pharma GmbH Solubilized Ibuprofen
EP1905428A1 (de) * 2006-09-26 2008-04-02 Losan Pharma GmbH Ibuprofen-Brausezubereitung mit hoher Lösungsgeschwindigkeit und Verfahren zu deren Herstellung
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
EP2309988B1 (en) * 2008-07-21 2015-11-25 SI Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
ES2763945T3 (es) * 2013-02-06 2020-06-01 Hermes Arzneimittel Gmbh Composiciones farmacéuticas que incorporan fármacos en dosis bajas
PL3157506T3 (pl) 2014-06-20 2021-03-08 Hermes Arzneimittel Gmbh Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions
GB2546513B (en) 2016-01-20 2020-09-16 Cubic Pharmaceuticals Ltd Process of preparing active pharmaceutical ingredient salts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
EP0070714B1 (en) * 1981-07-20 1986-05-07 The Upjohn Company Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen

Also Published As

Publication number Publication date
DE58900594D1 (de) 1992-01-30
HU895858D0 (en) 1990-02-28
ATE70438T1 (de) 1992-01-15
JP2735903B2 (ja) 1998-04-02
CA2002732A1 (en) 1990-05-12
JPH02178223A (ja) 1990-07-11
PT92271B (pt) 1995-08-09
FI895342A7 (fi) 1990-05-13
EP0369228A1 (de) 1990-05-23
PT92271A (pt) 1990-05-31
HU202103B (en) 1991-02-28
US5445827A (en) 1995-08-29
FI895342A0 (fi) 1989-11-09
HU211692A9 (en) 1995-12-28
DE3838431A1 (de) 1990-05-17
AU616066B2 (en) 1991-10-17
HUT51892A (en) 1990-06-28
GR3003685T3 (https=) 1993-03-16
AU4441789A (en) 1990-05-17
EP0369228B1 (de) 1991-12-18

Similar Documents

Publication Publication Date Title
ES2028430T3 (es) Preparaciones efervescentes de ibuprofen.
ES2071775T3 (es) Un granulo substituto de sal.
ES8303091A1 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
NL193307B (nl) Bruispreparaat met analgetische werkzaamheid.
ES2055894T3 (es) Concentrados de sustancias activas pesticidas y su preparacion.
MX174145B (es) Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico
AU550068B2 (en) Zinc insulin stabilized with calcium or magnesium salts
DK342989A (da) Betaendelseshaemmende middel
ES2134189T3 (es) Procedimiento para la preparacion de un producto de celulosa oxidado neutralizado y uso del mismo.
IL104348A (en) Hair preparation containing cysteamine and permanent wave method
IL31988A0 (en) An effervescent analgesic composition containing the components for the formation,upon dissolution in water,of a sodium-free salt of acetylsalicylic acid
ES512724A0 (es) Un procedimiento para la preparacion de una sal soluble en agua de lisina o arginina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
ES2061880T3 (es) Composicion y metodo de granulacion.
ES2099649T3 (es) Nueva composicion farmaceutica destinada para la fabricacion de un polvo estable que contiene, a titulo de ingrediente activo, una asociacion de acido acetilsalicilico y de metoclopramida.
ES2072647T3 (es) Composiciones que contienen sales de ranitidina/carboxilato de bismuto.
DK0468245T3 (da) Tablet og granulat indeholdende mesna som aktivt middel
ES2089613T3 (es) Composicion detergente.
ES2070624T3 (es) Instrucciones o elementos analogos para medicamentos.
ES2164849T3 (es) Soluciones acuosas con sabor enmascarado que contienen ibuprofeno y mentol.
GB1475861A (en) Pharmaceutical composition
GB1327560A (en) Effervescent pharmaceutical preparations
ES2061932T3 (es) Compuestos de teluro y derivados de selenio.
ES2086887T3 (es) Utilizacion de aguas madres de mareas salantes para la realizacion de una composicion de agua mar reconstituida.
孙铭一 et al. A NEW CHEMICAL MODEL OF TRACE-ELEMENTS PARTITIONED ON CLAY MINERALS IN SEAWATER

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 369228

Country of ref document: ES